Teva Pharmaceuticals

Teva Pharmaceuticals Operating Metrics

Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.

Teva Pharmaceuticals key operating metrics including Active Pharmaceutical Ingredients Production Facilities, environmental, and social and governance score (ESG).

Active Pharmaceutical Ingredients Production Facilities

5.6%

FY, 2019

Tablets and Capsules Produced

73B

8.8%

FY, 2019

Finished Dosage and Packaging Manufacturing Facilities

14.5%

FY, 2019

Operating Metrics

Metrics	FY, 2015	FY, 2016	FY, 2017	FY, 2018	FY, 2019
Active Pharmaceutical Ingredients Production Facilities	20	20	18	18	17
Tablets and Capsules Produced	61B	88B	88B	80B	73B
Finished Dosage and Packaging Manufacturing Facilities	40	69	62	55	47
Sterile Units Produced	700M	720M	720M	650M	753M
Tentative Approvals (United States)			84	92	79
Products Applications (United States)			343	297	251
Generic Approvals (Europe)			1.1K	734	660
Marketing Authorization Applications (Europe)			1.8K	1.3K	1.1K
Trials Products Approved (Respiratory)			3	2	2
Trials Products Submitted (Respiratory)			1	1
Phase III Trials Products (Respiratory)			1	1
Patents and Patent Applications (Active Pharmaceutical Ingredients)			600	650
Facilities			88	90	90
Facilities (United States)			17
Facilities (Europe)			33	31	34
Facilities (Rest of World)			38
Trials Products Approved (Neurology and Neuropsychiatry)			2
Phase III Trials Products (Neurology and Neuropsychiatry)			2
Phase II Trials Products (Neurology and Neuropsychiatry)			3
Trials Products Submitted (Migraine and Other Pain)			1
Phase III Trials Products (Migraine and Other Pain)			2
Phase II Trials Products (Migraine and Other Pain)			3
Products Launched (United States)			40
Phase III Trials Products (Migraine and Pain)				3	1
Facilities (North America)				21	19
Phase II Trials Products (Migraine and Pain)				1	2
Trials Products Approved (Oncology)				2	2
Products Launched (North America)				23	43
Facilities (International Markets)				38	37
Phase III Trials Products (CNS, Neurology and Neuropsychiatry)				3	3
Trials Products Under Regulatory Review (Respiratory)					2

Environmental, Social and Governance (ESG)

Overall

50-59 out of 100

Community

Employees

Environment

Governance

Premium Content only available in Craft’s Intelligence Portal

Learn more

Source:CSRHub

Footer menu

Product

Solutions

Resources

Company

Share price data provided by IEX